Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.73 +0.00 (+0.05%)
As of: Aug 21, 2026 · 9:53 AM EDT

Drugs Made In America Acquisition (DMAA) Treasury Shares (2025)

Drugs Made In America Acquisition's (DMAA) quarterly Treasury Shares came in at $23.0 million in Q4 2025, little changed on a QoQ basis from $23.0 million in Q3 2025.

Drugs Made In America Acquisition (DMAA) Treasury Shares (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 1 years of Treasury Shares data on file, last reported at $23.0 million in Q4 2025.

  • Quarterly Treasury Shares changed N/A year-over-year to $23.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.0 million (changed N/A YoY) and the FY2025 annual result came in at $23.0 million, changed N/A from the prior year.
  • Treasury Shares was little changed at $23.0 million in Q4 2025, from $23.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $23.0 million in Q1 2025 to a low of $23.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 25.30 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 23.00 Mn
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - 50.00 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 45.00 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 8.97 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 23.00 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -
8 Gores Holdings X 385.06 Mn 384.87 Mn - -
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 32.92 Mn
10 Drugs Made In America Acquisition 215.62 Mn 215.62 Mn - 13.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 23.00 Mn
Dec 31, 2025 23.00 Mn
Sep 30, 2025 23.00 Mn
Sep 30, 2025 23.00 Mn
Jun 30, 2025 23.00 Mn
Jun 30, 2025 23.00 Mn
Mar 31, 2025 23.00 Mn
Mar 31, 2025 23.00 Mn